3386 Stock Overview
Engages in the import, export, manufacture, marketing, and sale of life science research biotools.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 6/6 |
| Dividends | 4/6 |
Cosmo Bio Company,Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | JP¥1,159.00 |
| 52 Week High | JP¥1,159.00 |
| 52 Week Low | JP¥888.00 |
| Beta | 0 |
| 11 Month Change | 4.13% |
| 3 Month Change | 11.55% |
| 1 Year Change | 18.99% |
| 33 Year Change | 0.61% |
| 5 Year Change | 8.32% |
| Change since IPO | -42.91% |
Recent News & Updates
Recent updates
Cosmo Bio CompanyLimited's (TSE:3386) Shareholders Have More To Worry About Than Only Soft Earnings
Aug 12
Cosmo Bio CompanyLimited (TYO:3386) Is Experiencing Growth In Returns On Capital
May 09Cosmo Bio Company,Limited (TYO:3386) Vies For A Place In Your Dividend Portfolio: Here's Why
Mar 23Cosmo Bio Company,Limited's (TYO:3386) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?
Mar 02Will The ROCE Trend At Cosmo Bio CompanyLimited (TYO:3386) Continue?
Feb 07
Does Cosmo Bio CompanyLimited's (TYO:3386) Share Price Gain of 30% Match Its Business Performance?
Jan 17Should Cosmo Bio Company,Limited (TYO:3386) Be Part Of Your Dividend Portfolio?
Dec 23Do Fundamentals Have Any Role To Play In Driving Cosmo Bio Company,Limited's (TYO:3386) Stock Up Recently?
Dec 02Shareholder Returns
| 3386 | JP Healthcare | JP Market | |
|---|---|---|---|
| 7D | 4.9% | 1.2% | -1.7% |
| 1Y | 19.0% | 3.9% | 17.2% |
Return vs Industry: 3386 exceeded the JP Healthcare industry which returned 3.9% over the past year.
Return vs Market: 3386 exceeded the JP Market which returned 17.2% over the past year.
Price Volatility
| 3386 volatility | |
|---|---|
| 3386 Average Weekly Movement | 5.2% |
| Healthcare Industry Average Movement | 5.9% |
| Market Average Movement | 6.6% |
| 10% most volatile stocks in JP Market | 10.5% |
| 10% least volatile stocks in JP Market | 3.6% |
Stable Share Price: 3386 has not had significant price volatility in the past 3 months compared to the JP market.
Volatility Over Time: 3386's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1978 | 155 | Norihiko Shibayama | www.cosmobio.co.jp |
Cosmo Bio Company,Limited engages in the import, export, manufacture, marketing, and sale of life science research biotools. Its life science research tools include reagents, kits, instruments, software, and diagnostics products. The company offers research reagents, such as antibodies, antigens, biologically active substances, enzymes, substrates, peptides, amino acids, chemicals, carbohydrates, lipids, virus components, bacteria, and others, as well as offers detection reagents, cell and tissue culture systems, gene analysis systems, and others.
Cosmo Bio Company,Limited Fundamentals Summary
| 3386 fundamental statistics | |
|---|---|
| Market cap | JP¥6.75b |
| Earnings (TTM) | JP¥339.00m |
| Revenue (TTM) | JP¥9.64b |
19.9x
P/E Ratio0.7x
P/S RatioIs 3386 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 3386 income statement (TTM) | |
|---|---|
| Revenue | JP¥9.64b |
| Cost of Revenue | JP¥6.44b |
| Gross Profit | JP¥3.20b |
| Other Expenses | JP¥2.86b |
| Earnings | JP¥339.00m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
Nov 07, 2024
| Earnings per share (EPS) | 58.21 |
| Gross Margin | 33.17% |
| Net Profit Margin | 3.52% |
| Debt/Equity Ratio | 0.2% |
How did 3386 perform over the long term?
See historical performance and comparisonDividends
4.3%
Current Dividend Yield52%
Payout RatioDoes 3386 pay a reliable dividends?
See 3386 dividend history and benchmarks| Cosmo Bio CompanyLimited dividend dates | |
|---|---|
| Ex Dividend Date | Dec 27 2024 |
| Dividend Pay Date | Mar 27 2025 |
| Days until Ex dividend | 82 days |
| Days until Dividend pay date | 172 days |
Does 3386 pay a reliable dividends?
See 3386 dividend history and benchmarks